During a simulation visit, an adult daughter says her father has authorized her to speak for him and asks for his dose and side-effect details. The chart shows no documented representative, and a colleague is ready to walk her through the plan while the patient rests. Which disclosure decision best follows HIPAA and the Patient Care Partnership before anything is shared?

Ask the patient directly what information may be shared with his daughter, and honor the limits he sets for this visit. Her claim that he authorized her is not confirmation, and the chart lists no documented representative; asking him before disclosing avoids sharing information without established permission. Asking the patient to authorize discussion of his care does not justify giving his daughter the entire treatment-plan summary unless he specifically permits that scope. Verifying her identity and recording her report of permission do not establish his authorization, even if disclosure is limited to dose and side-effect details. Sharing information judged relevant to her caregiving role is also not justified merely because he is resting: that does not show he is unable to express a preference. Professional judgment may support limited disclosure in particular circumstances when a patient cannot be consulted, but that exception should not be assumed here. Exam caveat: HIPAA may allow relevant disclosures to involved family members in some situations, but relationship or a family member’s assertion alone does not create automatic access. Practical check: confirm the patient’s identity and ability to respond, ask which topics and details he permits sharing, and document the scope and any limits before speaking with his daughter.